Technical Analysis for TENX - Tenax Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 1.34 1.52% 0.02
TENX closed up 1.52 percent on Friday, September 20, 2019, on 17 percent of normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Flat
See historical TENX trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
20 DMA Support Bullish 1.52%
50 DMA Support Bullish 1.52%
1,2,3 Pullback Bullish Bullish Swing Setup 1.52%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.52%
20 DMA Support Bullish 3.08%
50 DMA Support Bullish 3.08%
Fell Below 200 DMA Bearish -0.74%
Upper Bollinger Band Walk Strength -0.74%
Crossed Above 200 DMA Bullish -6.29%

Older signals for TENX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company also develops Oxycyte, a systemic perfluorocarbon product for use as oxygen carrier in the situations of acute ischemia; and a range of perfluorocarbon-based oxygen carriers for use in personal care, topical wound healing, and other topical indications. Its Oxycyte is under Phase II-b clinical trials for the treatment of traumatic brain injury. In addition, the company offers Dermacyte line of topical cosmetic products that promote the appearance of skin health and other cosmetic benefits; and Wundecyte, a wound-healing gel. It sells Dermacyte through distribution agreements, on-line retailers, and direct sales to physician and medical spa facilities. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
Medicine Pharmaceutical Pharmaceutical Products Pharmacology Cardiac Surgery Topical Medication Traumatic Brain Injury Wound Healing
Is TENX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 6.39
52 Week Low 1.03
Average Volume 86,945
200-Day Moving Average 1.4025
50-Day Moving Average 1.296
20-Day Moving Average 1.3005
10-Day Moving Average 1.346
Average True Range 0.0826
ADX 43.07
+DI 24.7166
-DI 11.3111
Chandelier Exit (Long, 3 ATRs ) 1.2922
Chandelier Exit (Short, 3 ATRs ) 1.3878
Upper Bollinger Band 1.4175
Lower Bollinger Band 1.1835
Percent B (%b) 0.67
BandWidth 17.99308
MACD Line 0.0234
MACD Signal Line 0.0192
MACD Histogram 0.0042
Fundamentals Value
Market Cap 37.84 Million
Num Shares 28.2 Million
EPS -1.43
Price-to-Earnings (P/E) Ratio -0.94
Price-to-Sales 0.00
Price-to-Book 1.15
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.46
Resistance 3 (R3) 1.46 1.42 1.44
Resistance 2 (R2) 1.42 1.39 1.42 1.44
Resistance 1 (R1) 1.38 1.37 1.36 1.38 1.43
Pivot Point 1.34 1.34 1.33 1.34 1.34
Support 1 (S1) 1.30 1.31 1.28 1.30 1.25
Support 2 (S2) 1.26 1.29 1.26 1.24
Support 3 (S3) 1.22 1.26 1.24
Support 4 (S4) 1.22